Vivo Capital, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$35,000
+59.1%
4,1660.0%0.00%
+100.0%
Q4 2021$22,000
-99.3%
4,166
-99.1%
0.00%
-99.3%
Q3 2021$3,137,000
-79.4%
469,588
-73.8%
0.14%
-78.7%
Q2 2021$15,262,000
-3.7%
1,791,2570.0%0.66%
+18.7%
Q1 2021$15,853,000
-28.0%
1,791,2570.0%0.56%
-43.3%
Q4 2020$22,015,000
+51.0%
1,791,2570.0%0.98%
+16.5%
Q3 2020$14,581,000
-15.2%
1,791,2570.0%0.84%
-31.6%
Q2 2020$17,196,000
+41.2%
1,791,2570.0%1.23%
+11.8%
Q1 2020$12,181,000
-35.8%
1,791,2570.0%1.10%
-38.0%
Q2 2019$18,987,000
-24.2%
1,791,2570.0%1.78%
-28.8%
Q1 2019$25,042,000
+37.6%
1,791,2570.0%2.50%
+7.4%
Q4 2018$18,199,000
-15.3%
1,791,2570.0%2.32%
+7.3%
Q3 2018$21,495,000
-1.6%
1,791,2570.0%2.17%
-23.1%
Q2 2018$21,853,000
+23.9%
1,791,2570.0%2.82%
+12.7%
Q1 2018$17,644,000
-29.4%
1,791,2570.0%2.50%
-53.3%
Q4 2017$24,988,000
+27.1%
1,791,257
+0.2%
5.35%
+34.7%
Q3 2017$19,658,000
+39.2%
1,787,0910.0%3.97%
+11.7%
Q2 2017$14,118,000
-31.0%
1,787,0910.0%3.56%
-40.9%
Q1 2017$20,462,000
-1.7%
1,787,0910.0%6.02%
-12.3%
Q4 2016$20,820,000
-13.0%
1,787,0910.0%6.86%
-8.0%
Q3 2016$23,929,000
-24.5%
1,787,091
+11.7%
7.46%
-13.9%
Q2 2016$31,704,000
+18.2%
1,599,591
-0.0%
8.66%
+28.7%
Q1 2016$26,825,0001,599,5926.73%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 540,000$4,482,0004.68%
Knoll Capital Management, LLC 694,232$5,762,0003.62%
Telemetry Investments, L.L.C. 213,000$1,768,0002.79%
ACT CAPITAL MANAGEMENT, LLC 250,000$2,075,0002.20%
VR Adviser, LLC 1,469,767$12,199,0001.98%
INTERWEST VENTURE MANAGEMENT CO 560,990$4,656,0001.78%
683 Capital Management, LLC 3,375,000$28,013,0001.50%
Trellus Management Company, LLC 300,000$2,490,0001.45%
Altium Capital Management LP 440,000$3,652,0001.22%
CAXTON CORP 116,884$970,0001.21%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders